News

German fintech hits €12.5bn valuation in deal backed by Peter Thiel

Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Trade Republic

News

Editor's Top Picks

US defence act passes in rebuke to Trump administration’s stance on Europe

Unlock the White House Watch newsletter for freeYour guide to what Trump’s second term means for Washington, business and the

News

Your one-stop resource for personal news and tips.

Join our newsletter to get the latest news directly to your inbox.

More form News

AbbVie Vs. AstraZeneca: Battle Of The Pharmaceutical Behemoths (NYSE:ABBV)

In recent months, clouds have continued to gather over the pharmaceutical industry. This is due

Nervy investors pour $1tn into money market funds

Receive free Capital markets updatesWe’ll send you a myFT Daily Digest email rounding up the

Repurchase Agreement (Repo): What It Is And Examples

What Is a Repurchase Agreement? A Repurchase Agreement (or ‘Repo’ for short) is an agreement

General Motors chief assails UAW strikers in sign labour strife could escalate

Receive free Automobiles updatesWe’ll send you a myFT Daily Digest email rounding up the latest

Disney’s Stock May Be Ready To See A Big Rebound (NYSE:DIS)

Disney (NYSE:DIS) shares have been smashed since peaking in 2021 and have even returned to

Volodymyr Zelenskyy to meet Joe Biden in Washington in quest for more aid

Receive free War in Ukraine updatesWe’ll send you a myFT Daily Digest email rounding up

Anavex: Additional P2b/3 Alzheimer’s Trial Data Raises Additional Questions (NASDAQ:AVXL)

On Thursday, September 14, Anavex Life Sciences (NASDAQ:AVXL), a clinical-stage biopharmaceutical company which develops small

Instacart raises IPO price range after success of Arm listing

Receive free Instacart Inc updatesWe’ll send you a myFT Daily Digest email rounding up the

In Therapeutics Space, I Prefer Vicore Pharma Over Pliant Therapeutics

In April 2023, I wrote a SeekingAlpha article titled: Pliant Therapeutics: Bad Risk Reward, Buy

Boards tighten the rules on executives’ office romances

Receive free Corporate governance updatesWe’ll send you a myFT Daily Digest email rounding up the

Birchcliff Energy (BIREF): Higher 2024 Gas Prices Put Them In A Buy Zone

I want higher gas prices...and I want them NOW. Introduction Birchcliff Energy Ltd. (OTCPK:BIREF) is

‘There’s a rumbling now’: CEOs get into the business of tackling extremism

Receive free The Top Line updatesWe’ll send you a myFT Daily Digest email rounding up

Rising With The Tides: Solaris In The Oil Landscape (Rating Upgrade) (NYSE:SOI)

Introduction In my previous article, I talked about Solaris Oilfield Infrastructure (NYSE:SOI) as a stock

Meta mulls putting ads in WhatsApp as it seeks revenue boost

Receive free WhatsApp Inc updatesWe’ll send you a myFT Daily Digest email rounding up the

Unity: Buy The Backbone Of The Apple VisionPro And Meta Quest (NYSE:U)

Unity (NYSE:U) has been in the news due to game developer uproar over the latest